Duchenne Muscular Dystrophy
Screening for Duchenne muscular dystrophy
... Roses AD: Carrier testing of female relatives in pedi- grees of Duchenne muscular dystrophy patients.. Ann Neurol, to be published[r] ...
6
The role of lipid peroxidation in the pathogenesis of Duchenne muscular dystrophy
... THE ROLE OF LIPID PEROXIDATION IN THE PATHOGENESIS OF DUCHENNE MUSCULAR DYSTROPHY Jamaludin bin Mohamed A Thesis Submitted for the Degree of PhD at the University of St Andrews.. 1985 Fu[r] ...
315
Duchenne muscular dystrophy (DMD) detail study
... time. Duchenne Muscular Dystrophy is statistically considered the second most common type of muscular dystrophy ,the first common being facioscapulohumeral ...of dystrophy ...
6
The golden retriever model of Duchenne muscular dystrophy
... Duchenne muscular dystrophy (DMD) is an X-linked disease caused by mutations in the DMD gene and loss of the protein ...retriever muscular dystrophy (GRMD) dog, have played a key role ...
21
Clinical potential of ataluren in the treatment of Duchenne muscular dystrophy
... Abstract: Duchenne muscular dystrophy (DMD) is an autosomal dominant, X-linked neuromuscular disorder caused by mutations in dystrophin, one of the largest genes known to ...
12
Clinical utility of serum biomarkers in Duchenne muscular dystrophy
... Duchenne muscular dystrophy (DMD) is a severe form of myopathy that affects 1 in 5000–20,000 male births worldwide [1, 2]. It is due to frame shift mutations in the X-linked dystrophin gene ...
9
Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy
... therapy Duchenne muscular dystrophy (DMD) is a lethal X-linked progressive muscle-wasting disease caused by mutations, typically large deletions in the DMD gene, the largest gene in the human genome ...
6
Recent advances in Duchenne muscular dystrophy
... Abstract: Duchenne muscular dystrophy (DMD), an allelic X-linked progressive muscle- wasting disease, is one of the most common single-gene disorders in the developed ...
24
Left ventricular T2 distribution in Duchenne Muscular Dystrophy
... Duchenne Muscular Dystrophy (DMD), a lethal X- linked skeletal and cardiac myopathy, affects 1/3500 males [1]. DMD is caused by mutations in the dystro- phin gene resulting in greatly reduced or ...
8
Obesity and Endocrine Management of the Patient With Duchenne Muscular Dystrophy
... Duchenne muscular dystrophy (DMD) is associated with an increased risk of endocrine complications due to the effects of prolonged glucocorticoid therapy as well as progressive muscle ...
12
Psychosocial Management of the Patient With Duchenne Muscular Dystrophy
... In this article, we outline a comprehensive plan for the psychosocial management of patients with Duchenne muscular dystrophy (DMD) across the life span. In 2010, the Centers for Disease Control and ...
13
Nutritional and Gastrointestinal Management of the Patient With Duchenne Muscular Dystrophy
... Advances in treatment and multidisciplinary management have resulted in improved survival of individuals with Duchenne muscular dystrophy (DMD). Updated DMD treatment recommendations as found in the ...
11
Orthopedic and Surgical Management of the Patient With Duchenne Muscular Dystrophy
... Duchenne muscular dystrophy (DMD). In addition to progressive muscle weakness and loss of function, patients may develop joint contractures, scoliosis, and osteoporosis, causing fractures; all of ...
10
Current and emerging treatment strategies for Duchenne muscular dystrophy
... Abstract: Duchenne muscular dystrophy (DMD) is the most common form of muscular dystrophy in childhood. It is caused by mutations of the DMD gene, leading to progressive muscle ...
13
Computer task performance by subjects with Duchenne muscular dystrophy
... Aims: Two specific objectives were established to quantify computer task performance among people with Duchenne muscular dystrophy (DMD). First, we compared simple computational task performance ...
8
Reliability and validity of the Thai version of the Pediatric Quality of Life inventory™ 3.0 Duchenne Muscular Dystrophy module in Thai children with Duchenne Muscular Dystrophy
... Duchenne muscular dystrophy (DMD) is the most com- mon genetic neuromuscular disorder in children. The reported incidence of DMD ranges from 10.71 to 27.78 per 100,000 [1]. It is a chronic ...
8
Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy
... Background: Myostatin is a potent muscle growth inhibitor that belongs to the Transforming Growth Factor-b (TGF-b) family. Mutations leading to non functional myostatin have been associated with hypermuscularity in ...
10
Cardiac Management of the Patient With Duchenne Muscular Dystrophy
... the Duchenne Muscular Dystrophy Care Considerations Cardiology Management Working Group convened by the Centers for Disease Control and Prevention, drafted the initial outline for the manuscript, ...
12
Decreased Gait and Function in Duchenne Muscular Dystrophy
... Duchenne muscular dystrophy (DMD) is a genetic disorder linked to chromosome Xp21, due to absence of dystrophin ...of muscular dystrophies were ...
7
Biomarkers of Duchenne muscular dystrophy: current findings
... as Duchenne muscular dystrophy, this endeavor has created a wealth of knowledge that, if effectively exploited, will benefit affected individuals, with respect to health care, therapy, improved ...
13